Dr. Andreas Herbst

Dr. Andreas Herbst is currently serving as the Senior Brand & Customer Manager for WELIREG at MSD Deutschland since November 2021, where the focus is on the HIF2 alpha inhibitor Belzutifan and the Litespark Trial Program. Prior to this role, Dr. Herbst worked at Novartis Oncology for eight years, taking on various positions including Team Lead and Senior Disease Area Manager, with responsibilities that involved launching products in Chronic Myeloid Leukemia and representing the Hematology Marketing Team as a digital single-point-of-contact. Dr. Herbst's career also includes experiences as a Product Manager in both Hematology and Dermato-Oncology at Teva Pharmaceuticals and Cephalon, and has a solid educational background with a Doctorate in Molecular Biology from Ludwig-Maximilians-Universität München, an MBA from The Open University, and a Diploma in Biochemistry from The Martin Luther University of Halle-Wittenberg.